Login
← Go Back
Indegene
INDGN · Pharma > Pharmaceuticals & Drugs Listing date: May 13, 2024
Stock Price vs Company Growth
1d
1.6%
1w
5.2%
1m
12.8%
3m
10.8%
6m
16.7%
all
1.6%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowMar23Jun23Sep23Dec23Mar24Jun24Sep24Latest
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 580 1.6%
485
681
Company Overview
Sales
2,757 Cr
Growth: 7.0%
Profit after Tax
382 Cr
Growth: 2.9%
Mid Cap
13,916 Cr
P/E: 35.5x
Industry P/E: 29.5x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals
Sales (Cr) ₹ 2,757
Growth 7.0%
EBITDA 19.1%
P/S 5.1x
Dividend 0.0%
P/E 35.5x
Book Value ₹ 71.7
PEG Ratio 5.0x
ROE 24.3%
P/B 8.0x
Shareholding Pattern
Institutions
Created with Highcharts 8.2.2Jun24Sep24Dec24
Promoters
Created with Highcharts 8.2.2Jun24Sep24Dec24
Others
Created with Highcharts 8.2.2Jun24Sep24Dec24
Increase    Decrease    No change
Company Profile Detailed
The company’s Enterprise Commercial Solutions primarily involve assisting life sciences companies with their digital marketing operations. Service providers in this segment assist life sciences companies by creating customized marketing plans and campaigns, expanding their reach to healthcare professionals (HCPs), and providing insights on HCP preferences.
Belongs to (16 Indices) view more
Investors (3)
manish.g...
sanjay.s...
rajesh.b...
Followers (1)
varsha96